MRNA
Moderna, Inc.
Stock
$190.01+1.07 (+0.57%)Close Oct 2, 2026
Cash flow statement
| Line | Last 12 months | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | −$1.1B | −$1.9B | −$3.0B | −$3.1B | $5.0B | $13.6B | $2.0B | −$459M | −$331M | −$331M | $67M |
| Capital expenditures | $171M | $192M | $1.1B | $707M | $400M | $284M | $68M | $32M | $106M | $58M | $33M |
| Free cash flow | −$1.2B | −$2.1B | −$4.1B | −$3.8B | $4.6B | $13.3B | $2.0B | −$491M | −$437M | −$390M | $34M |
| Stock-based compensation | $462M | $483M | $429M | $305M | $226M | $142M | $93M | $81M | $73M | $40M | $39M |
| Buybacks | — | $2.0M | $0 | $1.2B | $3.3B | $857M | $0 | $0 | — | — | — |
| Free cash flow margin | −55.8% | −106.2% | −125.3% | −55.9% | 23.8% | 72.2% | 244.0% | −818.3% | −323.3% | −189.4% | 31.0% |